StonvexLoading…
StonvexStonvexStonvexCore line items from SWBI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-04-30 | Annual 2024 2024-04-30 | Annual 2023 2023-04-30 | Annual 2022 2022-04-30 |
|---|---|---|---|---|
Revenue | $474.66M | $535.83M | $479.24M | $864.13M |
Operating Income | $23.88M | $47.10M | $48.41M | $251.65M |
Net Income | $13.43M | $41.36M | $36.88M | $194.49M |
EPS (Diluted) | $0.30 | $0.89 | $0.80 | $4.08 |
Total Assets | $559.61M | $577.43M | $541.29M | $497.48M |
Total Liabilities | $187.16M | $177.51M | $156.67M | $136.96M |
Cash & Equivalents | $25.23M | $60.84M | $53.56M | $120.73M |
Free Cash Flow OCF − CapEx | $-28.83M | $15.98M | $-72.83M | $113.84M |
Shares Outstanding | 44.11M | 45.56M | 45.99M | 45.60M |